medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2014, Number 12

<< Back Next >>

Ginecol Obstet Mex 2014; 82 (12)

Postmenopausal symptoms severity enhancement oxidative stress in metabolic syndrome women’s

Zacarías-Flores M, Sánchez-Rodríguez MA, Correa-Muñoz E, Arronte-Rosales A, Mendoza-Núñez VM

Language: Spanish
References: 38
Page: 796-806
PDF size: 569.62 Kb.


ABSTRACT

Background: Oxidative stress is a serious imbalance between the reactive oxygen species (ROS) produced and the antioxidant systems, and has been identified to cause metabolic syndrome. Postmenopausal women (POS) with severe symptoms have higher oxidative stress; therefore it is possible to observe higher oxidative stress in postmenopausal women with metabolic syndrome and severe menopause related symptoms.
Objective: To determinate if the severe postmenopausal symptoms increased oxidative stress in women with metabolic syndrome .
Methods: We carry out a cross-sectional study with POS, 48 with metabolic syndrome and 52 healthy. Control group was defined as women heealthy and without severe symptoms (H-SS). Metabolic syndrome was defined according to criteria established by NCEP-ATPIII. We measured lipoperoxides by the TBARS assay as oxidative stress marker. All women answered the Menopause Rating Scale (MRS) that evaluates the severity of global symptoms in three dimensions: psychological, somatic and urogenital; and the Athens Insomnia Scale (AIS). In each questionnaire was used a cutoff value to determine the severity of symptoms and alternative cut-off value for lipoperoxides ≥0.320 _mol/L.
Results: The prevalence of high plasma lipoperoxides levels was higher in women with metabolic syndrome (WMS), 39 [81%] vs. 33 [64%], p‹ 0.05. The WMS, independent of severe symptoms (SS), had high lipoperoxides levels, similar to H+SS, except in urogenital MRS dimension and AIS. The risk of higher lipoperoxides increased with MS and severe symptoms RM=6.32, 95%CI: 1.32-30.20, p‹0.05, adjusted by others pro-oxidants factors.
Conclusion: Our findings suggest that the severity of menopausal related symptoms increased oxidative stress in women with metabolic syndrome .


REFERENCES

  1. Weiss G, Skurnick JH, Goldsmith LT, Santoro NF, Park SJ. Menopause and hypothalamic-pituitary sensitivity to estrogen. JAMA 2004;292:2991-2996.

  2. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocrin Rev 2009;30:465-493.

  3. Avis N, Brockwell S, Colvin A. A universal menopausal syndrome? Am J Med 2005;118:37S-46S.

  4. Troen BR. The biology of aging. Mt Sinai J Med 2003;70:3-22.

  5. Goldsmith TC. Aging theories and the zero-sum game. Rejuvenation Res 2014;17:1-2.

  6. Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008;60:10-18.

  7. Poehlman ET. Menopause, energy expenditure, and body composition. Acta Obstet Gynecol Scand 2002;81:603-611.

  8. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-2411.

  9. National Cholesterol Education Program (NCEP): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3121.

  10. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel (Adult Treatment Panel III). JAMA 2001;285:2486-2497.

  11. Cerdas-Pérez S. Síndrome metabólico en la peri y postmenopausia. Fármacos 2009;(Edición especial):58-61.

  12. Sánchez-Rodríguez MA, Martínez-Cruz M, Correa-Muñoz E, Mendoza-Núñez VM. Relationship between metabolic syndrome components and oxidative stress in elderly community- dwelling Mexicans. Ann Nutr Metab 2010;56:302-307.

  13. Sánchez-Rodríguez MA, Zacarías-Flores M, Arronte-Rosales A, Correa-Muñoz E, Mendoza-Núñez VM. Menopause as a risk factor for oxidative stress. Menopause 2012;19:361- 367.

  14. Harman D. Free radical theory of aging. Mutat Res 1992;275:257-266.

  15. Holvoet P, de Keyzer D, Jacobs Jr DR. Oxidized LDL and the metabolic syndrome. Future Lipidol 2008;3:637-649.

  16. Park SH, Kim JY, Lee JH, Park HY. Elevated oxidized lowdensity lipoprotein concentrations in postmenopausal women with the metabolic syndrome. Clin Chim Acta 2011;412:435-440.

  17. Sánchez-Rodríguez M, Mendoza-Núñez VM, García- Sánchez A, González-González B, Rodríguez-Torres E, González-Obregón A. Valores de referencia para poblaciones senecta y adulta de la Ciudad de México. Parámetros bioquímicos y hematológicos. Acta Bioquím Clin Latinoam 1998;32:397-405.

  18. Jentzsch AM, Bachmann H, Fürst P, Biesalski HK. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 1996;20:251-256.

  19. Heinemann LAJ, Potthoff P, Schneider HPG. International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcomes 2003;1:28.

  20. Menopause rating scale information. Available at: http:// www.menopause-rating-scale.info/documents/Ref_Values_ CountrGr.pdf. Accessed July 5, 2014.

  21. Soldatos CR, Dikeos DG, Paparrigopoulos TJ. Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria. J Psychosom Res 2000;48:555-560.

  22. Soldatos CR, Dikeos DG, Paparrigopoulos TJ. The diagnostic validity of the Athens Insomnia Scale. J Psychosom Res 2003;55:263-267.

  23. Monterossa A, Blumel J, Chedraui P. Increased menopausal symptoms among Afro-Colombian women as assessed with the Menopause Rating Scale. Maturitas 2008;59:182-190.

  24. Li C, Wilawan K, Samsioe G, Lidfeldt J, Agardh CD, Nerbrand C. Health profile of middle-aged women: The Women’s Health in the Lund Area (WHILA) study. Human Rep 2002;17:1379-1385.

  25. Chedraui P, Pérez-López FR, Aguirrea W, Calle A, Hidalgo L, León-León P, et al. Beliefs regarding menopausal hot flushes among climacteric women as assessed with the Hot Flush Beliefs Scale. Maturitas 2010;66:298-304.

  26. Venturini D, Simão AN, Scripes NA, Bahls LD, Melo PA, Belinetti FM, et al. Evaluation of oxidative stress in overweight subjects with or without metabolic syndrome. Obesity (Silver Spring) 2012;20:2361-236.

  27. Kim M, Paik JK, Kang R, Kim SY, Lee SH, Lee JH. Increased oxidative stress in normal-weight postmenopausal women with metabolic syndrome compared with metabolically healthy overweight/obese individuals. Metabolism 2013;62:554-560.

  28. Park S, Kim M, Paik JK, Jang YJ, Lee SH, Lee JH. Oxidative stress is associated with C-reactive protein in non-diabetic posmenopausal women, independent of obesity and insulin resistance. Clin Endocrinol 2013;79:65-70.

  29. Grattagliano I, Palmieri VO, Portincasa P, Moschetta A, Palasciano G. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem 2008;19:491-504.

  30. Freeman EW, Sammel MD, Sanders RJ. Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort. Menopause. 2014 Jan 27. [Epub ahead of print]

  31. Doshi SB, Agarwal A. The role of oxidative stress in menopause. J Midlife Health 2013;4:140-146.

  32. Deeks AA. Psychological aspects of menopause management. Best Pract Res Clin Endocrinol Metab 2003;17:17-31.

  33. Samsioe G, Dören M, Lobo RA. Acute symptoms of the menopause. Women’s Health Med 2006;3:282-286.

  34. Lesgards JF, Durand P, Lassarre M, Stricker P, Lesgards G, Lantaume A, Prost M, Lehucher-Michel MP. Assessment of lifestyle effects on the overall antioxidant capacity of healthy subjects. Environ Health Perspect 2002;110:479-486.

  35. Irie M, Asami S, Ikeda M, Kasai H. Depressive state related to female oxidative DNA damage via neutrophil activation. Biochem Biophys Res Communic 2003;311:1014-1018.

  36. Irie M, Miyata M, Kasai H. Depression and possible cancer risk due to oxidative DNA damage. J Psych Res 2005;39:553-560.

  37. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001;44:129-146.

  38. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996;334:3743-81.




2020     |     www.medigraphic.com